196 related articles for article (PubMed ID: 26762970)
1. The tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effects.
Holtermann N; Kiupel M; Hirschberger J
Vet Comp Oncol; 2017 Jun; 15(2):632-640. PubMed ID: 26762970
[TBL] [Abstract][Full Text] [Related]
2. Phase II clinical evaluation of lomustine chemotherapy for feline vaccine-associated sarcoma.
Saba CF; Vail DM; Thamm DH
Vet Comp Oncol; 2012 Dec; 10(4):283-91. PubMed ID: 22236148
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological and morphological analysis of feline injection site sarcomas.
Kliczkowska K; Jankowska U; Jagielski D; Czopowicz M; Sapierzyński R
Pol J Vet Sci; 2015; 18(2):313-22. PubMed ID: 26172181
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between p53 SNP and FISS in a cat population from Germany.
Mucha D; Laberke S; Meyer S; Hirschberger J
Vet Comp Oncol; 2014 Jun; 12(2):130-7. PubMed ID: 22882519
[TBL] [Abstract][Full Text] [Related]
5. Musings on feline injection site sarcomas.
Hendrick MJ
Vet J; 2011 May; 188(2):130-1. PubMed ID: 20696602
[No Abstract] [Full Text] [Related]
6. DNA damage is a feature of feline injection-site sarcoma.
Kang S; Southard T; Hume KR
Vet Comp Oncol; 2017 Jun; 15(2):518-524. PubMed ID: 26781433
[TBL] [Abstract][Full Text] [Related]
7. Toxicity and response in cats with neoplasia treated with toceranib phosphate.
Harper A; Blackwood L
J Feline Med Surg; 2017 Jun; 19(6):619-623. PubMed ID: 27090289
[TBL] [Abstract][Full Text] [Related]
8. The incidence of feline injection site sarcomas in the United Kingdom.
Dean RS; Pfeiffer DU; Adams VJ
BMC Vet Res; 2013 Jan; 9():17. PubMed ID: 23339769
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of toceranib phosphate (Palladia) when used in conjunction with other therapies in 35 cats with feline oral squamous cell carcinoma: 2009-2013.
Olmsted GA; Farrelly J; Post GS; Smith J
J Feline Med Surg; 2017 Jun; 19(6):568-575. PubMed ID: 26951557
[TBL] [Abstract][Full Text] [Related]
10. Vaccine-Associated Feline Sarcoma Task Force guidelines. Diagnosis and treatment of suspected sarcomas.
J Am Vet Med Assoc; 1999 Jun; 214(12):1745. PubMed ID: 10382012
[No Abstract] [Full Text] [Related]
11. Feline injection-site sarcoma: past, present and future perspectives.
Martano M; Morello E; Buracco P
Vet J; 2011 May; 188(2):136-41. PubMed ID: 20510635
[TBL] [Abstract][Full Text] [Related]
12. Progress made in feline sarcoma research.
O'Rourke K
J Am Vet Med Assoc; 2002 Mar; 220(6):734. PubMed ID: 11918259
[No Abstract] [Full Text] [Related]
13. Radical excision with five-centimeter margins for treatment of feline injection-site sarcomas: 91 cases (1998-2002).
Phelps HA; Kuntz CA; Milner RJ; Powers BE; Bacon NJ
J Am Vet Med Assoc; 2011 Jul; 239(1):97-106. PubMed ID: 21718202
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors for Injection-Site Sarcomas in Cats.
Harari J
Compend Contin Educ Vet; 2008 Oct; 30(10):E7. PubMed ID: 23705145
[TBL] [Abstract][Full Text] [Related]
15. Update on vaccine-associated sarcoma.
Leveque NW
J Am Vet Med Assoc; 1998 May; 212(9):1350. PubMed ID: 9589112
[No Abstract] [Full Text] [Related]
16. Clinical and low-field MRI characteristics of injection site sarcoma in 19 cats.
Rousset N; Holmes MA; Caine A; Dobson J; Herrtage ME
Vet Radiol Ultrasound; 2013; 54(6):623-9. PubMed ID: 23763538
[TBL] [Abstract][Full Text] [Related]
17. Nanocrystalline silver dressing and subatmospheric pressure therapy following neoadjuvant radiation therapy and surgical excision of a feline injection site sarcoma.
Woods S; de Castro Marques AI; Renwick MG; Argyle SA; Yool DA
J Feline Med Surg; 2012 Mar; 14(3):214-8. PubMed ID: 22370864
[TBL] [Abstract][Full Text] [Related]
18. Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study.
Chon E; McCartan L; Kubicek LN; Vail DM
Vet Comp Oncol; 2012 Sep; 10(3):184-93. PubMed ID: 22235941
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors.
Yancey MF; Merritt DA; Lesman SP; Boucher JF; Michels GM
J Vet Pharmacol Ther; 2010 Apr; 33(2):162-71. PubMed ID: 20444041
[TBL] [Abstract][Full Text] [Related]
20. Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats.
Poirier VJ; Thamm DH; Kurzman ID; Jeglum KA; Chun R; Obradovich JE; O'Brien M; Fred RM; Phillips BS; Vail DM
J Vet Intern Med; 2002; 16(6):726-31. PubMed ID: 12465772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
